Edwards Return On Equity from 2010 to 2025

EW Stock  USD 71.13  1.43  1.97%   
Edwards Lifesciences Return On Equity yearly trend continues to be fairly stable with very little volatility. Return On Equity will likely drop to 0.11 in 2025. Return On Equity is a measure of the profitability of Edwards Lifesciences Corp in relation to the equity, calculated by dividing net income by shareholder's equity. View All Fundamentals
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
0.19
Current Value
0.11
Quarterly Volatility
0.06717299
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Edwards Lifesciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Edwards Lifesciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 89.7 M, Interest Expense of 10.6 M or Selling General Administrative of 2.1 B, as well as many indicators such as Price To Sales Ratio of 4.36, Dividend Yield of 0.0 or PTB Ratio of 4.82. Edwards financial statements analysis is a perfect complement when working with Edwards Lifesciences Valuation or Volatility modules.
  
Check out the analysis of Edwards Lifesciences Correlation against competitors.

Latest Edwards Lifesciences' Return On Equity Growth Pattern

Below is the plot of the Return On Equity of Edwards Lifesciences Corp over the last few years. Return on Equity is the amount of Edwards Lifesciences Corp net income returned as a percentage of Edwards Lifesciences equity. Return on equity measures Edwards Lifesciences profitability by revealing how much profit Edwards Lifesciences Corp generates with the money shareholders have invested. It is a measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity. Edwards Lifesciences' Return On Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Edwards Lifesciences' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.1910 Years Trend
Very volatile
   Return On Equity   
       Timeline  

Edwards Return On Equity Regression Statistics

Arithmetic Mean0.21
Geometric Mean0.20
Coefficient Of Variation31.80
Mean Deviation0.05
Median0.21
Standard Deviation0.07
Sample Variance0
Range0.3031
R-Value0.03
Mean Square Error0
R-Squared0.001
Significance0.91
Slope0.0004
Total Sum of Squares0.07

Edwards Return On Equity History

2025 0.11
2024 0.19
2021 0.26
2018 0.23
2017 0.21
2016 0.22

About Edwards Lifesciences Financial Statements

Edwards Lifesciences investors use historical fundamental indicators, such as Edwards Lifesciences' Return On Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Edwards Lifesciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Equity 0.19  0.11 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Edwards Stock Analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.